We observed a mixture of CD44-positive and CD44-negative CD8+ T cells within MOC2-luc tumor tissue, suggesting that these CD44-positive CD8 T cells may be depleted upon CD44-targeted NIR-PIT (Figure S2). The gene discussed is CD8A; the disease is neoplasm.